Published in Protein Cell on October 07, 2010
Virulence factors of the Mycobacterium tuberculosis complex. Virulence (2012) 1.64
Rhodococcus erythropolis as a host for expression, secretion and glycosylation of Mycobacterium tuberculosis proteins. Microb Cell Fact (2017) 1.38
Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds. BMC Infect Dis (2011) 1.04
Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis. PLoS One (2014) 0.86
Interaction of Mycobacterium leprae with human airway epithelial cells: adherence, entry, survival, and identification of potential adhesins by surface proteome analysis. Infect Immun (2013) 0.80
Carbohydrate-dependent binding of langerin to SodC, a cell wall glycoprotein of Mycobacterium leprae. J Bacteriol (2014) 0.78
The presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10. Tuberculosis (Edinb) (2015) 0.77
Mycobacterium bovis requires P27 (LprG) to arrest phagosome maturation and replicate within bovine macrophages. Infect Immun (2016) 0.77
Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients. PLoS One (2016) 0.75
C-type lectins: their network and roles in pathogen recognition and immunity. Histochem Cell Biol (2016) 0.75
Generation and characterization of β1,2-gluco-oligosaccharide probes from Brucella abortus cyclic β-glucan and their recognition by C-type lectins of the immune system. Glycobiology (2016) 0.75
Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults. J Immunol Res (2015) 0.75
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
Dendritic cells and the control of immunity. Nature (1998) 56.54
ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res (2003) 17.39
In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc (2006) 16.56
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell (2000) 8.34
Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med (1995) 6.62
Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med (2003) 5.58
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med (1975) 4.73
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science (2001) 4.23
DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol (2003) 4.04
C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity (2007) 3.32
DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med (2003) 3.32
Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc Natl Acad Sci U S A (1995) 3.24
A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem (2001) 3.08
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A (2001) 2.86
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol (2004) 2.83
Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol (1997) 2.74
Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J (1996) 2.52
cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol (2001) 2.50
Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun (1996) 2.41
Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol (2003) 2.39
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A (2004) 2.38
DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol (2000) 2.38
Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol (2009) 2.00
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol (2004) 1.95
The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem (2002) 1.70
Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1987) 1.50
The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med (1989) 1.47
GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology (2001) 1.45
Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol (1993) 1.43
Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One (2007) 1.42
Mycobacterium tuberculosis expresses two chaperonin-60 homologs. Proc Natl Acad Sci U S A (1993) 1.39
The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J Bacteriol (1997) 1.38
Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain. Infect Immun (2001) 1.33
GroEL heat shock protein of Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells. Infect Immun (1998) 1.32
A novel 27 kDa lipoprotein antigen from Mycobacterium bovis. Microbiology (1997) 1.31
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis. Microbes Infect (2004) 1.25
Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J (2005) 1.16
CD209 genetic polymorphism and tuberculosis disease. PLoS One (2008) 1.14
A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection. Infect Immun (2008) 1.13
Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci U S A (1995) 1.10
Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol (1997) 1.08
SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor. Am J Physiol (1997) 1.06
Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infect Immun (2009) 1.05
Flow cytometric analysis of the heat shock protein 60 expressed on the cell surface of Helicobacter pylori. J Med Microbiol (1996) 1.05
The DnaK/DnaJ chaperone machinery of Salmonella enterica serovar Typhimurium is essential for invasion of epithelial cells and survival within macrophages, leading to systemic infection. Infect Immun (2004) 1.05
The Listeria monocytogenes DnaK chaperone is required for stress tolerance and efficient phagocytosis with macrophages. Cell Stress Chaperones (1999) 1.02
Analysis of post-translational modification of mycobacterial proteins using a cassette expression system. FEBS Lett (2000) 1.01
Multiple routes of complement activation by Mycobacterium bovis BCG. Mol Immunol (2009) 0.91
Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein. Microb Pathog (2000) 0.88
The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms. Immunobiology (2009) 0.85
Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D. Protein Cell (2010) 0.82
Surfactant protein A (SP-A) binds to phosphatidylserine and competes with annexin V binding on late apoptotic cells. Protein Cell (2010) 0.80
The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol (2004) 2.83
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol (2005) 2.82
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45
Functional significance of factor H binding to Neisseria meningitidis. J Immunol (2006) 2.39
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol (2004) 1.98
The cargo-selective retromer complex is a recruiting hub for protein complexes that regulate endosomal tubule dynamics. J Cell Sci (2010) 1.91
Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network. Nat Genet (2006) 1.88
Complement activation and protein adsorption by carbon nanotubes. Mol Immunol (2005) 1.81
His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79
Interactions between Neisseria meningitidis and the complement system. Trends Microbiol (2007) 1.72
Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect (2005) 1.67
Virulence factors of the Mycobacterium tuberculosis complex. Virulence (2012) 1.64
Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles. J Cell Biol (2012) 1.59
Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activation. Structure (2011) 1.55
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology (2008) 1.55
Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem (2004) 1.53
Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem (2007) 1.52
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood (2009) 1.51
The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. J Biol Chem (2007) 1.51
Paths reunited: Initiation of the classical and lectin pathways of complement activation. Immunobiology (2009) 1.50
Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem (2005) 1.47
Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater (2010) 1.45
Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J Immunol (2003) 1.43
Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One (2007) 1.42
C1q and its growing family. Immunobiology (2006) 1.40
Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem (2004) 1.40
Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 1.36
Carbohydrate-independent recognition of collagens by the macrophage mannose receptor. Eur J Immunol (2006) 1.30
Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science (2013) 1.27
Distinct and overlapping roles for AP-1 and GGAs revealed by the "knocksideways" system. Curr Biol (2012) 1.27
Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J Mol Biol (2013) 1.26
Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proc Natl Acad Sci U S A (2013) 1.24
Site-directed conjugation of "clicked" glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function. J Am Chem Soc (2007) 1.24
A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem (2005) 1.23
Evidence of a new role for the high-osmolarity glycerol mitogen-activated protein kinase pathway in yeast: regulating adaptation to citric acid stress. Mol Cell Biol (2004) 1.22
Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett (2006) 1.21
Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of mannosylated proteins. J Proteome Res (2009) 1.20
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem (2006) 1.19
Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol (2007) 1.19
The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. Infect Immun (2003) 1.18
A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics (2006) 1.17
Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology (2010) 1.17
The biological functions of MBL-associated serine proteases (MASPs). Immunobiology (2002) 1.16
Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis. Microbiology (2002) 1.15
Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol (2004) 1.15
The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol (2004) 1.12
Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation. Proc Natl Acad Sci U S A (2013) 1.12
Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Mol Biol Cell (2013) 1.12
Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A (2011) 1.12
Molecular organization of human Ficolin-2. Mol Immunol (2006) 1.11
Complement factor I in health and disease. Mol Immunol (2011) 1.10
The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim Biophys Acta (2008) 1.10
Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology (2009) 1.10
Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor. J Biol Chem (2006) 1.08
A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics (2006) 1.08
Complement in health and disease. Adv Drug Deliv Rev (2011) 1.08
Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle (2007) 1.07
Study of the role of Mce3R on the transcription of mce genes of Mycobacterium tuberculosis. BMC Microbiol (2008) 1.07
Glycosylation and the complement system. Chem Rev (2002) 1.06
Analogous interactions in initiating complexes of the classical and lectin pathways of complement. J Immunol (2009) 1.06
Comparative analysis of techniques to purify plasma membrane proteins. J Biomol Tech (2010) 1.05
Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds. BMC Infect Dis (2011) 1.04
Mannan binding lectin and viral hepatitis. Immunol Lett (2006) 1.03
The complement system in schizophrenia. Drug News Perspect (2008) 1.02
Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun (2003) 1.01
Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology (2004) 1.00
High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein. J Am Chem Soc (2010) 1.00
Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol (2007) 1.00
Mce3R, a TetR-type transcriptional repressor, controls the expression of a regulon involved in lipid metabolism in Mycobacterium tuberculosis. Microbiology (2009) 0.99
C1q binding and complement activation by prions and amyloids. Immunobiology (2007) 0.99
Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol Immunol (2009) 0.98
Microarray analysis of Mycobacterium microti reveals deletion of genes encoding PE-PPE proteins and ESAT-6 family antigens. Tuberculosis (Edinb) (2004) 0.98
Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J Biol Chem (2006) 0.98
Uptake and trafficking of liposomes to the endoplasmic reticulum. FASEB J (2010) 0.97
MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation. Proc Natl Acad Sci U S A (2013) 0.97
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum Mol Genet (2013) 0.97
Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J Proteome Res (2007) 0.96
Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc Natl Acad Sci U S A (2013) 0.95
Impact of the deletion of the six mce operons in Mycobacterium smegmatis. Microbes Infect (2012) 0.94
Proteomic plasma membrane profiling reveals an essential role for gp96 in the cell surface expression of LDLR family members, including the LDL receptor and LRP6. J Proteome Res (2012) 0.94
Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection. J Proteome Res (2009) 0.94
High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology (2010) 0.93
Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure. FEBS Lett (2004) 0.93
Recognition of acetylated oligosaccharides by human L-ficolin. Immunol Lett (2008) 0.93
Classical pathway complement activity in schizophrenia. Neurosci Lett (2005) 0.92
Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci Lett (2006) 0.92
Scrapie pathogenesis: the role of complement C1q in scrapie agent uptake by conventional dendritic cells. J Immunol (2009) 0.91
Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J Infect Dis (2006) 0.91
Multiple routes of complement activation by Mycobacterium bovis BCG. Mol Immunol (2009) 0.91
Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides. Biochim Biophys Acta (2006) 0.91
New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients. J Proteome Res (2011) 0.90
Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway. J Biol Chem (2007) 0.90
Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells. Chem Commun (Camb) (2011) 0.90